[Dimethylsulfoxide as a vehicle for vasoactive drugs in the treatment of systemic scleroderma].
D000293:Adolescent; D000328:Adult; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000008:administration & dosage*; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage*; D010184:Pancreatic Extracts / Q000008:administration & dosage*; D014677:Pharmaceutical Vehicles; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013454:Sulfoxides / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D009539:Nicotinic Acids; D010184:Pancreatic Extracts; D014677:Pharmaceutical Vehicles; D013454:Sulfoxides; D014665:Vasodilator Agents; C033969:angiotrofin; D007610:Kallikreins; D004121:Dimethyl Sulfoxide
Dimetisul'foksid kak provodnik vazoaktivnykh preparatov pri lechenii sistemnoĭ sklerodermii.